Correlation Between Madrigal Pharmaceuticals and Immunic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Immunic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Immunic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Immunic, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Immunic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Immunic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Immunic.

Diversification Opportunities for Madrigal Pharmaceuticals and Immunic

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Madrigal and Immunic is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Immunic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunic and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Immunic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunic has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Immunic go up and down completely randomly.

Pair Corralation between Madrigal Pharmaceuticals and Immunic

Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 2.46 times more return on investment than Immunic. However, Madrigal Pharmaceuticals is 2.46 times more volatile than Immunic. It trades about 0.05 of its potential returns per unit of risk. Immunic is currently generating about 0.02 per unit of risk. If you would invest  7,287  in Madrigal Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of  27,458  from holding Madrigal Pharmaceuticals or generate 376.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Madrigal Pharmaceuticals  vs.  Immunic

 Performance 
       Timeline  
Madrigal Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Madrigal Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Madrigal Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.
Immunic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immunic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Madrigal Pharmaceuticals and Immunic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Madrigal Pharmaceuticals and Immunic

The main advantage of trading using opposite Madrigal Pharmaceuticals and Immunic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Immunic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunic will offset losses from the drop in Immunic's long position.
The idea behind Madrigal Pharmaceuticals and Immunic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios